319 related articles for article (PubMed ID: 25412790)
1. Psoriasis: the future.
Menter MA; Griffiths CE
Dermatol Clin; 2015 Jan; 33(1):161-6. PubMed ID: 25412790
[TBL] [Abstract][Full Text] [Related]
2. Secukinumab (AIN-457) for the treatment of Psoriasis.
Jaleel T; Elmets C; Weinkle A; Kassira S; Elewski B
Expert Rev Clin Pharmacol; 2016; 9(2):187-202. PubMed ID: 26647300
[TBL] [Abstract][Full Text] [Related]
3. An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
Campa M; Ryan C; Menter A
Expert Opin Investig Drugs; 2015; 24(10):1343-54. PubMed ID: 26289788
[TBL] [Abstract][Full Text] [Related]
4. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword.
Gottlieb AB
Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S3-4. PubMed ID: 24777570
[No Abstract] [Full Text] [Related]
6. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
Leonardi CL
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
[TBL] [Abstract][Full Text] [Related]
7. Data on the safety of psoriasis therapies.
Leonardi CL
Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S73-5. PubMed ID: 25268600
[TBL] [Abstract][Full Text] [Related]
8. The status of biologic therapies in the treatment of moderate to severe psoriasis.
Menter A
Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
[TBL] [Abstract][Full Text] [Related]
9. Infections associated with the use of tumor necrosis factor-α inhibitors in psoriasis.
Tan X; Balkrishnan R; Feldman SR
J Drugs Dermatol; 2013 Mar; 12(3):e41-5. PubMed ID: 23545925
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of biologics in the treatment of pediatric psoriasis.
Luu M; Cordoro KM
Skin Therapy Lett; 2013 Feb; 18(2):1-4. PubMed ID: 23508772
[TBL] [Abstract][Full Text] [Related]
11. Time to Raise the Bar to Psoriasis Area Severity Index 90 and 100.
Manalo IF; Gilbert KE; Wu JJ
J Drugs Dermatol; 2015 Oct; 14(10):1086-8. PubMed ID: 26461817
[No Abstract] [Full Text] [Related]
12. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
Weinberg JM; Saini R
Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.
Famenini S; Wu JJ
Cutis; 2013 Sep; 92(3):140-7. PubMed ID: 24153143
[TBL] [Abstract][Full Text] [Related]
14. IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?
Torres T; Raposo I; Selores M
Am J Clin Dermatol; 2016 Apr; 17(2):107-12. PubMed ID: 26596991
[TBL] [Abstract][Full Text] [Related]
15. [Body-weight changes in psoriatic patients on systemic treatment].
Forien M; Mahé E; Sin C; Marchal A; Sigal ML
Ann Dermatol Venereol; 2012 Oct; 139(10):649-51. PubMed ID: 23122380
[No Abstract] [Full Text] [Related]
16. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD
Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069
[TBL] [Abstract][Full Text] [Related]
17. Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.
Böhner A; Roenneberg S; Eyerich K; Eberlein B; Biedermann T
JAMA Dermatol; 2016 Apr; 152(4):482-4. PubMed ID: 26650014
[No Abstract] [Full Text] [Related]
18. [Up-date on the use of infliximab in dermatology. Introduction].
Sánchez-Carazo J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
[No Abstract] [Full Text] [Related]
19. Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
[No Abstract] [Full Text] [Related]
20. Systemic therapy for psoriasis.
Lee M; Kalb RE
Dermatol Nurs; 2008 Apr; 20(2):105-11; quiz 112. PubMed ID: 18549125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
